Literature DB >> 10755710

Beryllium-stimulated production of tumor necrosis factor-alpha by a mouse hybrid macrophage cell line.

R T Sawyer1, L A Kittle, H Hamada, L S Newman, P A Campbell.   

Abstract

Chronic beryllium disease (CBD) results from exposure to the light-weight metal beryllium (Be). In vitro stimulation of bronchoalveolar lavage cells from CBD subjects causes the production of high levels of TNF-alpha, IFN-gamma and IL-6. We tested the hypothesis that Be-stimulation might induce the production of TNF-alpha by macrophage cell lines. We observed that H36.12j cells (12j), a mouse hybrid macrophage cell line, but not other mouse and human macrophage cell lines, produced TNF-alpha upon Be-stimulation. The response was maximal at 100 microM BeSO4 and did not occur when 12j cells were stimulated with either aluminum sulfate or cobalt sulfate. Beryllium-stimulated the production of 725+/-25 pg/ml (mean +/- SEM) TNF-alpha protein by 12j cells as measured by ELISA of culture supernatants after 24 h. As measured by RT-PCR, Be-stimulated 12j cell TNF-alpha protein production was accompanied by an increased intracellular TNF-alpha mRNA at 3 and 24 h. The addition of 10U or 100U of rMu-IFN-gamma to Be-stimulated 12j cells further increased TNF-alpha production 1.5-4 fold (1.6+/-0.1 ng/ml) respectively. Bacterial lipopolysaccharide (LPS, 1 microg/ml) stimulated production of TNF-alpha in 12j culture supernatants after 6 h (515+/-151 pg/ml). This early versus late TNF-alpha production suggests that LPS and Be both stimulate 12j cell TNF-alpha synthesis, but through different pathways. We report for the first time, the direct effects of Be stimulation on the ability of 12j cells to produce TNF-alpha. The 12j cell line, contrasted with other macrophage hybrids that do not respond to Be-stimulation, may provide a useful tool to evaluate the mechanisms by which Be stimulates macrophage cytokine production, and by which T cell derived IFN-gamma amplifies TNF-alpha production in granulomatous diseases.

Entities:  

Mesh:

Substances:

Year:  2000        PMID: 10755710     DOI: 10.1016/s0300-483x(99)00182-1

Source DB:  PubMed          Journal:  Toxicology        ISSN: 0300-483X            Impact factor:   4.221


  7 in total

1.  Fas promoter polymorphisms: genetic predisposition to sarcoidosis in African-Americans.

Authors:  Y S Wasfi; L J Silveira; A Jonth; J E Hokanson; T Fingerlin; H Sato; C E Parsons; P Lympany; K Welsh; R M du Bois; L S Newman; L A Maier
Journal:  Tissue Antigens       Date:  2008-07

2.  Beryllium-induced TNF-alpha production is transcription-dependent in chronic beryllium disease.

Authors:  Richard T Sawyer; Andrew P Fontenot; Tristan A Barnes; Charles E Parsons; Brian C Tooker; Lisa A Maier; May M Gillespie; E Brigitte Gottschall; Lori Silveira; James Hagman; Lee S Newman
Journal:  Am J Respir Cell Mol Biol       Date:  2006-09-15       Impact factor: 6.914

Review 3.  Immunologic Effects of Beryllium Exposure.

Authors:  Andrew P Fontenot
Journal:  Ann Am Thorac Soc       Date:  2018-04

Review 4.  Beryllium-Induced Hypersensitivity: Genetic Susceptibility and Neoantigen Generation.

Authors:  Andrew P Fontenot; Michael T Falta; John W Kappler; Shaodong Dai; Amy S McKee
Journal:  J Immunol       Date:  2016-01-01       Impact factor: 5.422

5.  Circular RNA expression profiles in human bronchial epithelial cells treated with beryllium sulfate.

Authors:  Yan-Ping Liu; Ying Cai; Yuan-di Lei; Xiao-Yan Yuan; Ye Wang; Shan Yi; Xun-Ya Li; Lian Huang; Ding-Xin Long; Zhao-Hui Zhang
Journal:  Toxicol Res (Camb)       Date:  2021-08-27       Impact factor: 2.680

6.  The uses and adverse effects of beryllium on health.

Authors:  Ross G Cooper; Adrian P Harrison
Journal:  Indian J Occup Environ Med       Date:  2009-08

7.  CpG promoter methylation status is not a prognostic indicator of gene expression in beryllium challenge.

Authors:  Brian C Tooker; Katherine Ozawa; Lee S Newman
Journal:  J Immunotoxicol       Date:  2015-12-16       Impact factor: 3.000

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.